Brandeis and Brigham and Women's Hospital license technology for Gaucher's to Amicus Therapeutics
Waltham, MABrandeis University and Brigham and Women's Hospital today agreed to grant a license option to Amicus Therapeutics for a jointly-developed novel pharmaceutical technology that could be instrumental in finding new treatments for Gaucher Disease. Biochemists Raquel Lieberman, Gregory Petsko and Dagmar Ringe, each affiliated with both Brandeis and Brigham and Women's, invented a patentab...CAMBRIDGE, Mass.--Ultra-small particles loaded with medicine - and aimed with the precision of a rifle - are offering a promising new way to strike at cancer, according to researchers working at MIT and Brigham and Women's Hospital....... In a paper to appear the week of April 10 in the online edition of the Proceedings of the National Academy of Sciences, the team reports a way to custom design...